Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1445142
This article is part of the Research Topic Exploring Frontiers: Molecular Diagnostics and Therapeutics Insights View all articles

Cross comparison of alternative diagnostic protocols including substitution to the clinical sample, RNA extraction method and nucleic acid amplification technology for COVID-19 diagnosis Authors

Provisionally accepted
  • 1 University of Costa Rica, San José, Costa Rica
  • 2 Instituto de Investigaciones Farmacéuticas (INIFAR), San Jose, Costa Rica
  • 3 Agencia Costarricense de Investigaciones Biomédicas (ACIB) - Fundación INCIENSA (FUNIN), San Jose, Costa Rica
  • 4 Gorgas Memorial Institute of Health Studies, Panama City, Panama
  • 5 Laboratory of Experimental and Applied Microbiology, Fluminense Federal University, Niterói, Brazil
  • 6 University of Panama, Panama City, Panama
  • 7 Other, San Salvador, El Salvador
  • 8 University of El Salvador, San Salvador, San Salvador, El Salvador
  • 9 School of Biology, Faculty of Sciences, University of Costa Rica, San Pedro, Costa Rica

The final, formatted version of the article will be published soon.

    Background: the gold-standard diagnostic protocol (GSDP) for COVID-19 consists of a nasopharyngeal swab (NPS) sample processed through traditional RNA extraction (TRE) and amplified with retrotranscription quantitative polymerase chain reaction (RT-qPCR). Multiple alternatives were developed to decrease time/cost of GSDP, including alternative clinical samples, RNA extraction methods and nucleic acid amplification. Thus, we carried out a cross comparison of various alternatives methods against GSDP and each other. Methods: we tested alternative diagnostic methods using saliva, heatinduced RNA release (HIRR) and a colorimetric retrotranscription loop-mediated isothermal amplification (RT-LAMP) as substitutions to the GSDP. Results: RT-LAMP using NPS processed by TRE showed high sensitivity (96%) and specificity (97%), closely matching GSDP. When saliva was processed by TRE and amplified with both RT-LAMP and RT-qPCR, RT-LAMP yielded high diagnostic parameters (88-96% sensitivity and 95-100% specificity) compared to RT-qPCR. Nonetheless, when saliva processed by TRE and detected by RT-LAMP was compared against the GSDP, the resulting diagnostic values for sensitivity (78%) and specificity (87%) were somewhat high but still short of those of the GSDP. Finally, saliva processed with HIRR and detected via RT-LAMP was the simplest and fastest method, but its sensitivity against GSDP was too low (56%) for any clinical application. Also, in this last method, the acidity of a large percentage of saliva samples (9-22%) affected the pH-sensitive colorimetric indicator used in the test, requiring the exclusion of these acidic samples or an extra step for pH correction. Discussion: our comparison shows that RT-LAMP technology has diagnostic performance on par with RT-qPCR; likewise, saliva offers the same diagnostic functionality as NPS when subjected to a TRE method. Nonetheless, use of direct saliva after a HIRR and detected with RT-LAMP does not produce an acceptable diagnostic performance.

    Keywords: RT-LAMP, COVID-19, saliva sample, Alternative protocol, SARS-CoV-2

    Received: 06 Jun 2024; Accepted: 31 Jul 2024.

    Copyright: © 2024 Segura-Ulate, Apú, Cortés, Zaldívar, Querol-Audi, Ortega, Flores-Mora, Madrigal-Redondo and Gatica-Arias. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ismael Segura-Ulate, University of Costa Rica, San José, Costa Rica

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.